Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[HBs-antigen-positive chronic aggressive hepatitis].

R Müller, F W Schmidt

    Fortschritte Der Medizin
    |April 26, 1984
    PubMed
    Summary

    Treating HBs-Ag positive chronic aggressive hepatitis remains challenging. Current methods like immunosuppression, immunostimulation, and antiviral drugs show limited success, with relapses common after treatment discontinuation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Characterization of new gibberellin-responsive semidwarf mutants of arabidopsis.

    Plant physiology·1997
    Same author

    [Use of a Coffea arabica tosta extract for the prevention and therapy of polyfactorial infectious diseases in newborn calves].

    DTW. Deutsche tierarztliche Wochenschrift·1996
    Same author

    [The effect of vitamin A and beta-carotene on the vitamin E status, ejaculation parameters and health of boar used for insemination].

    DTW. Deutsche tierarztliche Wochenschrift·1996
    Same author

    [Follow-up studies of the detection of IgG1 antibodies to Coxiella burnetii in blood and milk from cattle in relation to the reproductive cycle and milk production].

    DTW. Deutsche tierarztliche Wochenschrift·1994
    Same author

    Reduced metabolic efficiency in patients with Crohn's disease.

    Digestive diseases and sciences·1993
    Same author

    Enzyme diagnosis of liver diseases.

    Clinical biochemistry·1993

    Area of Science:

    • Hepatology
    • Immunology
    • Virology

    Background:

    • Chronic aggressive hepatitis B (HBs-Ag positive) presents complex treatment challenges.
    • Existing therapeutic strategies include immunosuppression, immunostimulation, and antiviral agents.
    • The efficacy and safety of these treatments in HBs-Ag positive patients require careful consideration.

    Purpose of the Study:

    • To evaluate the effectiveness of current therapeutic approaches for HBs-Ag positive chronic aggressive hepatitis.
    • To assess the risks and benefits associated with immunosuppressive, immunostimulatory, and antiviral therapies.
    • To identify potential breakthroughs or limitations in managing this condition.

    Main Methods:

    • Review of established treatment modalities for hepatitis B.
    • Analysis of outcomes associated with immunosuppression (glucocorticoids, azathioprine).
    • Evaluation of immunostimulation (BCG vaccine, Propionibacterium granulosum) and antiviral treatments (vidarabine).

    Main Results:

    • Immunosuppressive therapy is considered risky and potentially counterproductive in HBs-Ag positive cases, possibly enhancing viral replication.
    • Immunostimulation has shown occasional remissions, but results are inconsistent.
    • Antiviral treatments like vidarabine can inhibit viral propagation but often lead to relapses upon discontinuation, with lasting success being rare.

    Conclusions:

    • Current therapeutic options for HBs-Ag positive chronic aggressive hepatitis have significant limitations.
    • Immunosuppression poses risks and is of doubtful benefit.
    • Neither immunostimulation nor available virostatic agents have provided definitive breakthroughs, highlighting the need for novel treatment strategies.

    Related Experiment Videos